Company intelligence / Profile preview

CARDIX Therapeutics LLC

San Diego, California, United Statescardixtherapeutics.com ↗

Ownership: Private
Development stage: Preclinical

Overview

CARDIX-101 is currently in Phase 2 clinical trials for the treatment of chronic bradycardia. The company completed a Phase 1/2 exploratory safety and efficacy clinical study that started in December 2022.

Therapeutic areas: Cardiovascular
Modalities: Small molecules
Industry: Biotech

Drug pipeline

1 asset

CARDIX-101

Beyond the preview

Go deeper on CARDIX Therapeutics LLC.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CARDIX Therapeutics LLC.

Explore the full profile